about
Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinologyTumor necrosis factor-α regulates distinct molecular pathways and gene networks in cultured skeletal muscle cellsRegulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.Locomotion and muscle mass measures in a murine model of collagen-induced arthritis.Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in miceCombination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblastsHigher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans.Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation.The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases.TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokineTumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathwayGenetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.Low-level laser therapy improves the inflammatory profile of rats with heart failure.Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.Biomedical consequences of alcohol use disorders in the HIV-infected hostNuclear factor-kappa B signaling in skeletal muscle atrophy.Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx miceDynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure.The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.Agents Which Inhibit NF-κB Signaling Block Spontaneous Contractile Activity and Negatively Influence Survival of Developing Myotubes.A conceptual framework: the early and late phases of skeletal muscle dysfunction in the acute respiratory distress syndrome.A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African AmericansMuscle torque relative to cross-sectional area and the functional muscle-bone unit in children and adolescents with chronic disease.A direct HDAC4-MAP kinase crosstalk activates muscle atrophy programThe phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.Heightened TWEAK-NF-κB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury.Akt in the pathogenesis of COPD.Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy.Increased expression of atrogenes and TWEAK family members after severe burn injury in nonburned human skeletal muscle.Proinflammatory cytokine tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) suppresses satellite cell self-renewal through inversely modulating Notch and NF-κB signaling pathways.TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction.Detection of calprotectin and apoptotic activity in the colon of marmosets with chronic diarrhea.Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?Various jobs of proteolytic enzymes in skeletal muscle during unloading: facts and speculations.Insulin-like growth factor-I (IGF-I) and clinical nutrition.Current understanding of sarcopenia: possible candidates modulating muscle mass.Acute rhabdomyolysis and inflammation.Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1/2 Activation: Implications in Myogenic Differentiation
P2860
Q28386983-ECCCE258-FCEB-46F9-BD23-2E73C849F368Q28475735-E2CFDD84-3FD6-4912-AA8C-3F42A6292EFCQ28658848-EE4496AC-8669-4B4E-B3FD-825D45FB62A7Q33459510-45BB7668-3849-4C4D-83D1-35738B6765BBQ33526358-F4B532F9-0315-4782-9579-50F86173D777Q33554610-B01080A8-20C9-49D5-ABB0-1F061B5ACB62Q33654592-15C9FB23-6EF2-4AE7-AF71-C7EB64DFCDCBQ33673668-5DF34841-6146-4333-9D39-2B6327AE6730Q33751732-05C07BFD-4067-4BF0-8C23-809300B1D83BQ33901722-1327D2AC-146A-4817-9CFA-F637A6F3E67BQ34132291-9296FF9E-35DD-48D1-A150-DAA0C9ED7518Q34132318-07F050ED-95AC-4C0B-AC63-27E245BBC4CCQ34132341-1D27AD58-74F5-4A75-B90D-550C1717488EQ34162346-B372FC85-67B6-4B23-B1BE-479B23856177Q34398672-0AE08E48-AC6D-435A-8410-3E938138D10EQ34439637-CC4F3EDB-8028-49AD-A969-3554E6A1477CQ34464076-0C148E21-ABD4-4098-BF91-2A169D9150F8Q34593476-F887B68E-0D9C-44C6-96E7-667AD6093A0EQ34973330-59B105AF-2AAF-4C1A-8C77-3D4B6864010AQ35581324-F340EF23-7EB7-4DD2-BAF4-414DCD75F34EQ35671234-CB15AF5F-980F-4B79-9F1D-A7D8E08F9E5EQ35679235-4D4CFB1C-D8C6-4459-AE1F-2F8C529B1AC3Q35809472-40B1EF08-9A0F-45E0-8AF4-9FF6B64AA10DQ35889200-F563C5DC-352A-457C-8F72-BB9B5810E23BQ35939993-757FD79F-D59D-4E09-8DC7-7FE490224327Q36098729-DC741D36-6E95-41BA-ACDE-B11CB6A2D7B6Q36240664-7D4B457B-B8A8-4930-B166-3E85877FC291Q36955270-32238F68-CCEA-4B3F-8A18-51E5468940E9Q37018918-4C84A632-435B-4F3A-A734-E91C80EF3E58Q37066013-3FE5ECF3-F15B-4191-BF72-C68F4070DCA7Q37164742-8DA5D947-803A-4DFD-B089-990F52B9A9A1Q37368645-AECE7675-3343-4850-9BA2-003707E301AEQ37516544-0B6790D1-0588-4A3B-A860-14AA6F745881Q37618259-6ED6C7FB-BA9A-4641-A2DC-CF59DC6EB21BQ37825936-AF04051E-7309-473D-913B-E7FC5931825BQ38002018-84FC09D6-4138-4430-8D04-8220CE488BBFQ38110572-3944B191-9FCF-4391-9A8A-0AA96C09AD68Q38209436-CBBC8AF1-C44C-494C-A3E1-7DA972B8ACB8Q38380755-D96ABA3D-CCAF-4EF0-8DCF-5C85E1EA6B41Q38723327-F413F93A-1D78-4C4B-8522-909FDA5BE235
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Proinflammatory cytokines and skeletal muscle.
@ast
Proinflammatory cytokines and skeletal muscle.
@en
type
label
Proinflammatory cytokines and skeletal muscle.
@ast
Proinflammatory cytokines and skeletal muscle.
@en
prefLabel
Proinflammatory cytokines and skeletal muscle.
@ast
Proinflammatory cytokines and skeletal muscle.
@en
P1476
Proinflammatory cytokines and skeletal muscle.
@en
P2093
P Christian Schulze
Ulrike Späte
P304
P356
10.1097/00075197-200405000-00005
P577
2004-05-01T00:00:00Z